NASDAQ: SCHL
SCHOLASTIC CORPCIK 0000866729 · SIC 2731 · Books
Mid
Revenue $1.6B
Assets $1.7B
as of Sep 6, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WLTH 10-Q) is open in full — no account needed.
8-K
Filed Aug 27, 2026
· Period ending Aug 27, 2026
Summary not yet generated.
10-K
Filed Jul 24, 2026
· Period ending May 31, 2026
Summary not yet generated.
Partner
Trade SCHL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jul 23, 2026
· Period ending Jul 23, 2026
Summary not yet generated.
10-Q
Filed Mar 20, 2026
· Period ending Feb 28, 2026
Summary not yet generated.
8-K
Filed Mar 19, 2026
· Period ending Mar 19, 2026
Summary not yet generated.
8-K
Filed Mar 19, 2026
· Period ending Mar 19, 2026
Summary not yet generated.
10-Q
Filed Dec 19, 2025
· Period ending Nov 30, 2025
Summary not yet generated.
10-K
Filed Jul 25, 2025
· Period ending May 31, 2025
Summary not yet generated.
10-K/A
Filed Sep 30, 2024
· Period ending May 31, 2024
Summary not yet generated.
Latest financial statements
From 10-K filed Jul 24, 2026 (period ending May 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations
(Amounts in millions, except per share data)
| Description | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenues | 1,581.9 | 1,625.5 | 1,589.7 |
| Operating costs and expenses | |||
| Cost of goods sold | 689.8 | 718.8 | 705.1 |
| Selling, general and administrative expenses | 807.2 | 822.3 | 803.0 |
| Depreciation and amortization | 58.8 | 65.7 | 57.1 |
| Asset impairments and write downs | 10.9 | 2.9 | 10.0 |
| Total operating costs and expenses | 1,566.7 | 1,609.7 | 1,575.2 |
| Operating income (loss) | 15.2 | 15.8 | 14.5 |
| Interest income | 2.9 | 2.2 | 4.6 |
| Interest expense | (14.1) | (18.2) | (1.9) |
| Other components of net periodic benefit (cost) | (1.3) | (1.1) | (1.0) |
| Loss on sale of investments | (17.2) | — | — |
| Gain on sale and leaseback transactions | 99.7 | — | — |
| Earnings (loss) before income taxes | 85.2 | (1.3) | 16.2 |
| Provision (benefit) for income taxes | 28.5 | 0.6 | 4.1 |
| Net income (loss) | 56.7 | (1.9) | 12.1 |
| Basic and diluted earnings (loss) per share of Class A and Common Stock | |||
| Basic: | |||
| Net Income (loss) | 2.39 | (0.07) | 0.41 |
| Diluted: | |||
| Net Income (loss) | 2.34 | (0.07) | 0.40 |
| Dividends declared per share of Class A and Common Stock | 0.80 | 0.80 | 0.80 |
Consolidated Balance Sheets
(Amounts in millions)
| Description | 2026 | 2025 |
|---|---|---|
| Current Assets: | ||
| Cash and cash equivalents | 134.9 | 124.0 |
| Accounts receivable, net | 236.4 | 273.4 |
| Inventories, net | 265.0 | 250.2 |
| Income tax receivable | 28.4 | 8.8 |
| Tax credit receivable | 19.3 | 21.0 |
| Prepaid expenses and other current assets | 37.3 | 47.9 |
| Total current assets | 721.3 | 725.3 |
| Noncurrent Assets: | ||
| Property, plant and equipment, net | 201.6 | 516.3 |
| Prepublication costs, net | 41.1 | 49.7 |
| Investment in film and television programs, net | 40.4 | 42.1 |
| Operating lease right-of-use assets, net | 291.2 | 103.9 |
| Royalty advances, net | 64.6 | 78.1 |
| Goodwill | 199.4 | 198.9 |
| Other intangible assets, net | 77.9 | 87.9 |
| Noncurrent deferred income taxes | 31.8 | 34.7 |
| Other assets and deferred charges | 58.8 | 113.2 |
| Total noncurrent assets | 1,006.8 | 1,224.8 |
| Total assets | 1,728.1 | 1,950.1 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities: | ||
| Lines of credit and current portion of long-term debt | 5.5 | 6.2 |
| Film related obligations | 17.1 | 18.3 |
| Accounts payable | 144.2 | 157.3 |
| Accrued royalties | 50.3 | 69.1 |
| Deferred revenue | 179.2 | 178.8 |
| Other accrued expenses | 158.1 | 166.2 |
| Accrued income taxes | 4.7 | 3.7 |
| Operating lease liabilities | 26.4 | 26.8 |
| Total current liabilities | 585.5 | 626.4 |
| Noncurrent Liabilities: | ||
| Long-term debt | 75.0 | 250.0 |
| Operating lease liabilities | 280.6 | 91.5 |
| Other noncurrent liabilities | 36.2 | 35.7 |
| Total noncurrent liabilities | 391.8 | 377.2 |
| Commitments and Contingencies: | — | — |
| Stockholders’ Equity: | ||
| Preferred Stock, $1.00 par value: Authorized, 2.0 shares; Issued and Outstanding, none | — | — |
| Class A Stock, $0.01 par value: Authorized, 3.2 shares; Issued and Outstanding, 0.8 shares. | 0.0 | 0.0 |
| Common Stock, $0.01 par value: Authorized, 70.0 shares; Issued, 42.9 shares; Outstanding, 17.9 and 24.2 shares, respectively | 0.4 | 0.4 |
| Additional paid-in capital | 602.5 | 607.1 |
| Accumulated other comprehensive income (loss) | (35.9) | (41.5) |
| Retained earnings | 1,037.6 | 999.7 |
| Treasury stock at cost: 25.0 and 18.7 shares, respectively | (853.8) | (619.2) |
| Total stockholders’ equity | 750.8 | 946.5 |
| Total liabilities and stockholders’ equity | 1,728.1 | 1,950.1 |
Consolidated Statements of Cash Flows
(Amounts in millions)
| Description | 2026 | 2025 | 2024 |
|---|---|---|---|
| Cash flows - operating activities: | |||
| Net income (loss) | 56.7 | (1.9) | 12.1 |
| Adjustments to reconcile Net income (loss) to net cash provided by (used in) operating activities: | |||
| Provision for losses on accounts receivable | 6.5 | 5.0 | 5.2 |
| Provision for losses on inventory | 8.9 | 16.1 | 20.4 |
| Provision for losses on royalty advances | 6.2 | 5.7 | 2.7 |
| Amortization of prepublication costs | 21.6 | 21.9 | 26.2 |
| Amortization of film and television programs | 11.9 | 9.9 | — |
| Depreciation and amortization | 71.8 | 78.5 | 67.0 |
| Amortization of pension and postretirement plans | 0.8 | 0.5 | 0.4 |
| Deferred income taxes | 3.6 | (19.7) | (1.9) |
| Stock-based compensation | 8.5 | 9.3 | 11.0 |
| Income from equity method investments | (0.3) | (0.5) | (0.5) |
| Loss on sale of investments | 17.2 | — | — |
| Non cash write off related to asset impairments and write downs | 10.9 | 2.9 | 10.0 |
| Gain on sale and leaseback transactions | (99.7) | — | — |
| Changes in assets and liabilities, net of amounts acquired: | |||
| Accounts receivable | 31.4 | (26.7) | 38.2 |
| Inventories | (22.5) | (2.8) | 50.9 |
| Income tax receivable | (19.6) | 6.8 | (6.3) |
| Tax credit receivable | 1.6 | 10.6 | — |
| Prepaid expenses and other current assets | 7.4 | 4.1 | (1.7) |
| Investment in film and television programs | (12.1) | (12.5) | — |
| Royalty advances | 7.6 | (25.8) | (3.4) |
| Employee benefit plan contribution | (8.6) | — | — |
| Accounts payable | (13.8) | 15.5 | (32.5) |
| Accrued royalties | (19.4) | 13.3 | (4.5) |
| Deferred revenue | (0.1) | 7.5 | (8.1) |
| Other accrued expenses | (10.5) | (1.5) | (10.3) |
| Accrued income taxes | 1.0 | 1.7 | (11.5) |
| Other, net | (16.1) | 6.3 | (8.8) |
| Net cash provided by (used in) operating activities | 50.9 | 124.2 | 154.6 |
| Cash flows - investing activities: | |||
| Prepublication expenditures | (17.9) | (24.5) | (22.8) |
| Additions to property, plant and equipment | (48.4) | (52.2) | (58.4) |
| Net proceeds from sale and leaseback transactions | 452.4 | — | — |
| Net proceeds from sale of investments | 19.4 | — | — |
| Return of capital from investments | 0.3 | — | — |
| Acquisition-related payments | — | (176.2) | (6.4) |
| Purchase of noncontrolling interests | — | — | (2.1) |
| Net cash provided by (used in) investing activities | 405.8 | (252.9) | (89.7) |
| Cash flows - financing activities: | |||
| Borrowings under lines of credit, credit agreement and revolving loan | 234.3 | 305.9 | 54.1 |
| Repayments of lines of credit, credit agreement and revolving loan | (409.8) | (57.4) | (54.1) |
| Borrowings under film related obligations | 17.5 | 16.5 | — |
| Repayments of film related obligations (including interests) | (18.5) | (34.8) | — |
| Repayment of capital lease obligations | (2.1) | (1.7) | (2.3) |
| Reacquisition of common stock | (265.9) | (70.0) | (158.2) |
| Proceeds pursuant to stock-based compensation plans | 18.6 | 1.2 | 9.1 |
| Payment of dividends | (20.0) | (22.6) | (24.7) |
| Other, net | (0.1) | 0.2 | — |
| Net cash provided by (used in) financing activities | (446.0) | 137.3 | (176.1) |
| Effect of exchange rate changes on cash and cash equivalents | 0.2 | 1.7 | 0.4 |
| Net increase (decrease) in cash and cash equivalents | 10.9 | 10.3 | (110.8) |
| Cash and cash equivalents at beginning of period | 124.0 | 113.7 | 224.5 |
| Cash and cash equivalents at end of period | 134.9 | 124.0 | 113.7 |
Amounts as printed on the EDGAR/iXBRL face — (Amounts in millions, except per share data); (Amounts in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗